Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001048477-25-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-20 | BMRN | Hubbard Cristin | EVP, Chief Commercial Off | F - Tax | $59.93 | -2,155 | 30.5K | -7% | -$129.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-20 | F | D | 2,155 | $59.93 | 30,545 | D | — | — |